Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021

Publisher Name :
Date: 15-Sep-2016
No. of pages: 175
Inquire Before Buying

The sepsis diagnostics market is expected to reach USD 564.1 million by 2021, at a CAGR of 8.8% from 2016 to 2021.

The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis in the neonate and adult population across the globe. In addition, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market.

In this report, the sepsis diagnostics market has been segmented on the basis of product (instruments, blood culture media, assay kits & reagents, and software),technology (microbiology, molecular diagnostics, immunoassays, and flow cytometry), usability (laboratory testing & point-of-care testing), method (conventional diagnostics and automated diagnostics),pathogen (bacterial sepsis, fungal sepsis, and others) and region (North America, Europe, APAC, and RoW). On the basis of products, the blood culture media segment is estimated to account for the largest share of the sepsis diagnostics market in 2016. High use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis is driving the growth of this segment across the globe.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the sepsis diagnostics market in 2016, followed by Europe. A number of factors such as the high prevalence of sepsis, increasing number of invasive procedures, growing adoption of high-end sepsis diagnostics devices, and rising government support are contributing to the growth of the North American sepsis diagnostics market. However, lack of standard protocol for sepsis diagnostics and high cost of diagnostic devices are limiting the growth of sepsis diagnostics market in the North America.

The sepsis diagnostics market consists of a large number of big, medium, and small-sized companies. As of 2015, the sepsis diagnostics market was dominated by bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Cepheid Inc. (U.S.). New product launches and product approvals; partnerships, agreements, and collaborations; and acquisitions; were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the sepsis diagnostics market.

Objectives Of The Study


  • To define, describe, and forecast the global sepsis diagnostics market on the basis of technology, products, method, usability, pathogen, and region

  • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market

  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

  • To provide a five-year forecast for various segments of the sepsis diagnostics market, in terms of revenue, with respect to four main regions, namely, North America (the U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (India, China, Japan, and the Rest of Asia-Pacific), and the Rest of the World

  • To strategically profile the key players and comprehensively analyze their market shares and core competencies

  • To track and analyze competitive developments such as new product launches,; agreements and partnerships,; and mergers and acquisitions in the global sepsis diagnostics market


1. Micro markets are defined as the further segments and subsegments of the global sepsis diagnostics market included in the report.

2. Core competencies of the companies are captured in terms of their key developments and key strategies adopted to maintain their market positions.

Target Audience:


  • Sepsis diagnostic device manufacturing companies

  • Clinical laboratories

  • Hospitals and clinics

  • Research institutes and clinical research organizations (CROs)

  • Market research and consulting firms

  • Sepsis diagnostic devices suppliers and distributors

  • Blood culture media manufacturers

  • Blood culture media distributors and suppliers


Scope of the Report

This research report categorizes the sepsis diagnostics market into the following segments:

Global Sepsis Diagnostics Market, by Technology


  • Microbiology

  • Molecular Diagnostics

  • Immunoassays

  • Flow Cytometry


Global Sepsis Diagnostics Market, by Product


  • Blood Culture Media

  • Instruments

  • Assays & Reagents

  • Software


Global Sepsis Diagnostics Market, by Method


  • Conventional Diagnostics

  • Automated Diagnostics


Global Sepsis Diagnostics Market, by Usability


  • Laboratory Testing

  • Point-of-care Testing


Global Sepsis Diagnostics Market, by Pathogen


  • Bacterial Sepsis

    • Gram-negative Bacterial Sepsis

    • Gram-positive Bacterial Sepsis



  • Fungal Sepsis

  • Others


Global Sepsis Diagnostics Market, by Region


  • North America

    • U.S.

    • Canada



  • Europe

    • Germany

    • France

    • U.K.

    • Rest of Europe



  • Asia-Pacific

    • India

    • China

    • Japan

    • Rest of Asia-Pacific



  • Rest of the World

Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.3 Market Size Estimation Methodology
2.1.3.1 Bottom-Up Approach
2.1.3.2 Top-Down Approach
2.1.4 Research Design
2.1.5 Market Data Validation and Triangulation
2.1.6 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Attractive Market Opportunities in the Global Sepsis Diagnostics
4.2 Geographic Analysis: Sepsis Diagnostics Market, By Product
4.3 Sepsis Diagnostics Market Size, By Technology, 2016 vs 2021
4.4 Sepsis Diagnostics Market Size, By Method and Region, 2016
4.5 Sepsis Diagnostics Market Size, By USAbility, 2016 vs 2021
4.6 Sepsis Diagnostics Market Size, By Pathogen, 2016 vs 2021

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Sepsis in the Neonate and Adult Population
5.2.1.2 Rising Incidence of Sepsis in Geriatric Population
5.2.1.3 Increasing Number of Preterm Births
5.2.1.4 Growing Incidence of Hospital-Acquired Infections
5.2.1.5 Increasing Number of Surgical Procedures
5.2.1.6 Growing Pneumonia Cases
5.2.1.7 Influx of Novel Sepsis Diagnostic Products
5.2.2 Restraints
5.2.2.1 High Cost of Automated Diagnostic Devices
5.2.2.2 Lack of Established Reimbursement for Sepsis
5.2.3 Opportunities
5.2.3.1 Increasing Funding for Sepsis-Related Research Activities
5.2.3.2 Development of Rapid Diagnostic Techniques for Early Sepsis Diagnosis
5.2.3.3 Evolution of Procalcitonin Test as A Novel Biomarker for Sepsis Diagnosis
5.2.3.4 Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
5.2.3.5 Growing Number of Regulatory Approvals for Sepsis Diagnostic Products
5.2.4 Challenges
5.2.4.1 Lack of Standard Protocols and Awareness for Sepsis Diagnosis and Treatment
5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, By Product
6.1 Introduction
6.2 Instruments
6.3 Blood Culture Media
6.4 Assay Kits & Reagents
6.5 Software

7 Sepsis Diagnostics Market, By Technology
7.1 Introduction
7.2 Microbiology
7.3 Molecular Diagnostics
7.4 Immunoassays
7.5 Flow Cytometry

8 Sepsis Diagnostics Market, By Method
8.1 Introduction
8.2 Conventional Diagnostics
8.3 Automated Diagnostics

9 Sepsis Diagnostics Market, By USAbility
9.1 Introduction
9.2 Laboratory Testing
9.3 Point-Of-Care Testing

10 Sepsis Diagnostics Market, By Pathogen
10.1 Introduction
10.2 Bacterial Sepsis
10.2.1 Gram-Negative Bacterial Sepsis
10.2.2 Gram-Positive Bacterial Sepsis
10.3 Fungal Sepsis
10.4 Other Pathogen Infections

11 Sepsis Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Growing Prevalence of Sepsis
11.2.1.2 Increasing Incidences of Hais
11.2.1.3 Increasing Government Support for Sepsis Research
11.2.1.4 Growing Product Approvals
11.2.1.5 Rising Initiatives to Drive the Adoption of Sepsis Diagnostic Tools
11.2.1.6 Lack of Standard Protocol for Sepsis Diagnosis Hinders Market Growth
11.2.1.7 High Cost of Treatment
11.2.2 Canada
11.2.2.1 Expanding Patient Population Base
11.2.2.2 Support for the Development of Novel Sepsis Diagnostic Products
11.2.2.3 Growing Focus on Sepsis Management
11.2.2.4 Low Awareness Related to Sepsis Management
11.2.2.5 Dearth of Training Leading to Inadequate Patient Assessment
11.3 Europe
11.3.1 Germany
11.3.1.1 High Incidence of Sepsis
11.3.1.2 Growing Funding for Sepsis Research
11.3.1.3 Initiatives By the German Sepsis Society
11.3.1.4 High Awareness Related to the Sepsis Management
11.3.1.5 Development of Novel Sepsis Diagnostics Products
11.3.1.6 Poor Implementation of Guidelines Related to the Sepsis Management
11.3.2 U.K.
11.3.2.1 Growing Initiatives By Government Organizations
11.3.2.2 Increasing Awareness Among Medical Staff and General Practitioners
11.3.2.3 Rising Focus Towards the Development of New Sepsis Diagnostics Devices
11.3.2.4 Rising Demand for Diagnostic Devices
11.3.2.5 Dearth of Paramedics
11.3.3 France
11.3.3.1 Growing Number of Symposiums and Conferences
11.3.3.2 High Prevalence of Sepsis
11.3.3.3 Growth in Research Funding for Sepsis Diagnosis
11.3.4 Rest of Europe (RoE)
11.3.4.1 Hub for Various Sepsis Related Conferences
11.3.4.2 Rapid Growth in the Aging Population
11.3.4.3 Initiatives to Diagnose Neonatal Sepsis
11.3.4.4 Rising Focus on the Development of Advanced Products
11.4 Asia-Pacific
11.4.1 Japan
11.4.1.1 Increasing Incidence of Healthcare-Associated Infections
11.4.1.2 Growing Aging Population
11.4.1.3 Increasing Initiatives By Market Players
11.4.1.4 Lack of Proper Reimbursement for Sepsis
11.4.2 China
11.4.2.1 Large Number of Ongoing Clinical Studies
11.4.2.2 Developing Healthcare Infrastructure
11.4.2.3 Limited Implementation of Surviving Sepsis Campaign (SSC)
11.4.3 India
11.4.3.1 High Sepsis Burden
11.4.3.2 Rising Antibiotic Resistance
11.4.3.3 Rising Number of Icu Patients
11.4.3.4 Increasing Number of Surgical Procedures
11.4.3.5 Rising Focus of Local and Global Players
11.4.3.6 Shortage of Medical Staff in India
11.4.3.7 Lack of Awareness Leading to Death Due to Sepsis
11.4.4 Rest of Asia-Pacific
11.4.4.1 Large Number of Ongoing Conferences
11.4.4.2 Rising Initiatives to Increase Awareness About Sepsis
11.4.4.3 Significant Patient Population Base in Malaysia
11.4.4.4 South Korea Presents Significant Growth Opportunities
11.4.4.5 Lack of Established Sepsis Management Guidelines
11.4.4.6 Lack of Reimbursement for Sepsis
11.5 Rest of the World
11.5.1.1 Increasing Antibiotic Resistance Among Patients
11.5.1.2 Initiatives to Improve Healthcare in Middle East Countries
11.5.1.3 High Prevalence of Cancer and Hiv in the Region
11.5.1.4 Key Challenges to Market Growth in the Region

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product Approvals
12.3.2 Collaborations, Acquisitions, and Partnerships
12.3.3 New Product Launches
12.3.4 Other Strategies

13 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Introduction
13.2 Biomérieux SA
13.3 Becton, Dickinson and Company
13.4 Thermo Fisher Scientific Inc.
13.5 Abbott Laboratories, Inc.
13.6 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
13.7 Cepheid Inc.
13.8 T2 Biosystems, Inc.
13.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
13.10 Nanosphere, Inc. (A Luminex Company)
13.11 Bruker Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix
14.1 Discussion Guide
14.2 Other Developments
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT : Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List of Tables

Table 1 Sepsis Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 2 Sepsis Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 3 Blood Culture Media Market Size, By Region, 2014-2021 (USD Million)
Table 4 Assay Kits & Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 5 Software Market Size, By Region, 2014-2021 (USD Million)
Table 6 Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 7 Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 8 Molecular Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 9 Immunoassays Market Size, By Region, 2014–2021 (USD Million)
Table 10 Flow Cytometry Market Size, By Region, 2014–2021 (USD Million)
Table 11 Sepsis Diagnostics Market Size, By Method, 2014-2021 (USD Million)
Table 12 Conventional Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 13 Automated Diagnostic Market Size, By Region, 2014–2021 (USD Million)
Table 14 Sepsis Diagnostics Market Size, By Usability, 2014-2021 (USD Million)
Table 15 Parameters Tested in Sepsis Diagnosis
Table 16 Laboratory Testing Market Size, By Region, 2014-2021 (USD Million)
Table 17 Point-Of-Care Testing Market Size, By Region, 2014-2021 (USD Million)
Table 18 Sepsis Diagnostics Market Size, By Pathogen, 2014-2021 (USD Million)
Table 19 Bacterial Sepsis Market Size, By Type, 2014-2021 (USD Million)
Table 20 Bacterial Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 21 Fungal Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 22 Other Pathogen Infections Market Size, By Region, 2014-2021 (USD Million)
Table 23 Sepsis Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 26 North America: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 27 North America: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 28 North America: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 29 North America: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 30 U.S.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 31 U.S.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 32 U.S.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 33 U.S.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 34 U.S.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 35 Canada: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Canada: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 37 Canada: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 38 Canada: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 39 Canada: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 40 Europe: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 42 Europe: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 43 Europe: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 44 Europe: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 45 Europe: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 46 Germany: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 47 Germany: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 48 Germany: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 49 Germany: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 50 Germany: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 51 U.K.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 52 U.K.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 53 U.K.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 54 U.K.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 55 U.K.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 56 France: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 57 France: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 58 France: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 59 France: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 60 France: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 61 RoE: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 62 RoE: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 63 RoE: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 64 RoE: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 65 RoE: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 66 APAC: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 67 APAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 68 APAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 69 APAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 70 APAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 71 APAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 72 Japan: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 73 Japan: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 75 Japan: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 76 Japan: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 77 China: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 79 China: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 80 China: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 81 China: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 82 India: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 83 India: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 84 India: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 85 India: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 86 India: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 87 RoAPAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 88 RoAPAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 89 RoAPAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 90 RoAPAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 91 RoAPAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 92 RoW: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 93 RoW: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 95 RoW: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 96 RoW: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 97 Top 5 Product Approvals, 2013–2016
Table 98 Top 5 Collaborations, Acquisition, and Partnerships, 2013–2016
Table 99 Top 4 New Product Launches, 2013–2016
Table 100 Top 5 Other Strategies, 2013–2016

List of Figures

Figure 1 Sepsis Diagnostics Market Segmentation
Figure 2 Global Sepsis Diagnostics Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Sepsis Diagnostics Market, By Product, 2016
Figure 7 Global Sepsis Diagnostics Market, By Technology, 2016 (USD Million)
Figure 8 Global Sepsis Diagnostics Market, By Method, 2016 vs 2021
Figure 9 Global Sepsis Diagnostics Market, By Usability, 2016 vs 2021
Figure 10 Global Sepsis Diagnostics Market, By Pathogen, 2016 vs 2021
Figure 11 Global Sepsis Diagnostics Market, By Region, 2016 (USD Million)
Figure 12 Increasing Prevalence of Sepsis—Primary Driver of the Sepsis Diagnostics Market
Figure 13 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 14 Microbiology Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 15 Conventional Diagnostics Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 16 Laboratory Testing Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 17 Bacterial Sepsis Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 18 Sepsis Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Chances of Developing Sepsis Increase With Age, 2014
Figure 20 Patient Survival Rate in Sepsis Cases
Figure 21 Blood Culture Media Segment to Witness Higher Growth During the Forecast Period (2016- 2021)
Figure 22 North America to Dominate the Instruments Market in 2016
Figure 23 Asia-Pacific to Witness Highest Growth in the Blood Culture Media Market, 2016
Figure 24 North America to Dominate the Assay Kits & Reagents Market in 2016
Figure 25 Asia-Pacific to Witness Highest Growth in the Software Segment (2016-2021)
Figure 26 Molecular Diagnostics Segment to Witness High Growth During the Forecast Period (2016-2021)
Figure 27 North America to Dominate the Microbiology Market in 2016
Figure 28 Asia-Pacific to Witness Highest Growth in the Molecular Diagnostics Market in 2016
Figure 29 North America to Dominate the Immunoassays Market in 2016
Figure 30 North America to Dominate the Flow Cytometry Market in 2016
Figure 31 Conventional Diagnostics Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 32 North America to Dominate the Conventional Diagnostics Market in 2016
Figure 33 Asia-Pacific to Witness High Growth in the Automated Diagnostics Segment During the Forecast Period, 2016-2021
Figure 34 POCT Segment to Witness Highest Growth During the Forecast Period, 2016-2021
Figure 35 North America to Dominate the Laboratory Testing Market in 2016
Figure 36 Asia-Pacific to Witness Highest Growth in the Point-Of-Care Testing Segment (2016-2021)
Figure 37 Bacterial Sepsis Segment to Witness Highest Growth, 2016–2021
Figure 38 Gram-Negative Bacteria Segment to Dominate the Bacterial Sepsis Market in 2016
Figure 39 Asia-Pacific to Witness Higher Growth During the Forecast Period, (2016-2021)
Figure 40 North America to Dominate the Fungal Sepsis Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth in the Other Pathogens Segment in 2016
Figure 42 Sepsis Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Sepsis Diagnostics Market Snapshot
Figure 44 Europe: Sepsis Diagnostics Market Snapshot
Figure 45 APAC: Sepsis Diagnostics Market Snapshot
Figure 46 Global Sepsis Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: Product Approvals the Key Strategy
Figure 48 Geographic Revenue Mix of the Top Players
Figure 49 Biomérieux Sa: Company Snapshot
Figure 50 Becton, Dickinson and Company: Company Snapshot
Figure 51 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 52 Abbott Laboratories, Inc.: Company Snapshot
Figure 53 Roche Diagnostics Limited: Company Snapshot
Figure 54 Cepheid: Company Snapshot
Figure 55 T2 Biosystems, Inc.: Company Snapshot
Figure 56 Danaher Corporation: Company Snapshot
Figure 57 Luminex Corporation: Company Snapshot
Figure 58 Bruker Corporation: Company Snapshot

  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Europe Endocrine Testing Systems Sales Market Report 2021
    Published: 04-Aug-2016        Price: US 4900 Onwards        Pages: 118
    This report studies sales (consumption) of Endocrine Testing Systems in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific - AdnaGen - ImmunoDX - Immunonodiagnostics System -......
  • Europe Genetic Testing Sales Market Report 2021
    Published: 04-Aug-2016        Price: US 4900 Onwards        Pages: 123
    This report studies sales (consumption) of Genetic Testing in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Qiagen - Roche - Abbott - Hologic - 23andMe - Affymetrix - Luminex - Invitae - GeneDx - Shanghai Genmed - Shanghai Koyee - Yinhe Jiyin......
  • US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 02-Aug-2016        Price: US 9800 Onwards        Pages: 620
    Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the next five years. The report examines trends in the US market; revi......
  • Global Endocrine Testing Systems Sales Market Report 2021
    Published: 29-Jul-2016        Price: US 4000 Onwards        Pages: 128
    This report studies sales (consumption) of Endocrine Testing Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific - AdnaGen - ImmunoDX - Immunonodiagnostic......
  • Global Genetic Testing Sales Market Report 2021
    Published: 29-Jul-2016        Price: US 4000 Onwards        Pages: 128
    This report studies sales (consumption) of Genetic Testing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Qiagen - Roche - Abbott - Hologic - 23andMe - Affymetrix - Luminex - Invitae - GeneDx - Shanghai Genmed - Shanghai Koyee -......
  • United States Endocrine Testing Systems Sales Market Report 2021
    Published: 27-Jul-2016        Price: US 3800 Onwards        Pages: 120
    This report studies sales (consumption) of Endocrine Testing Systems in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific - AdnaGen - ImmunoDX - Immunonodiagnostics System - InDevR - Innogenetics - Kyowa Medex - Merck Millipore - Meridian Bioscienc......
  • United States Genetic Testing Sales Market Report 2021
    Published: 27-Jul-2016        Price: US 3800 Onwards        Pages: 121
    This report studies sales (consumption) of Genetic Testing in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Qiagen - Roche - Abbott - Hologic - 23andMe - Affymetrix - Luminex - Invitae - GeneDx - Shanghai Genmed - Shanghai Koyee - Yinhe Jiyin - Angel Biological - Beijing Sunbiotech Split by product types, with sales, re......
  • Global Genetic Testing Market Research Report 2021
    Published: 18-Jul-2016        Price: US 2900 Onwards        Pages: 130
    This report studies Genetic Testing in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering Qiagen Roche Abbott Hologic 23andMe Affymetrix Luminex Invitae GeneDx Shanghai Genmed Shanghai Koyee Yinhe Jiyin......
  • Australia Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
    Published: 15-Jul-2016        Price: US 4500 Onwards        Pages: 40
    This new report from VPGMarketResearch provides granular analysis of the Australia diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs